Item 1. Financial Statements.
UAS DRONE CORP.
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF SEPTEMBER 30, 2022
UAS DRONE CORP.
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF SEPTEMBER 30, 2022
TABLE OF CONTENTS
UAS DRONE CORP.
CONDENSED CONSOLIDATED
BALANCE SHEETS
(USD in thousands, except share and per share data)
| |
September 30, | | |
December 31, | |
| |
2022 | | |
2021 | |
| |
(Unaudited) | | |
| |
Assets | |
| | |
| |
Current Assets | |
| | |
| |
Cash and cash equivalents | |
| 3,010 | | |
| 3,560 | |
Other current assets | |
| 36 | | |
| 40 | |
Total Current assets | |
| 3,046 | | |
| 3,600 | |
| |
| | | |
| | |
Lease deposit | |
| 15 | | |
| - | |
| |
| | | |
| | |
Property and equipment, net | |
| 22 | | |
| 9 | |
Total assets | |
| 3,083 | | |
| 3,609 | |
| |
| | | |
| | |
Liabilities and Shareholders’ Equity | |
| | | |
| | |
Current Liabilities | |
| | | |
| | |
Accounts payable | |
| 87 | | |
| 75 | |
Other accounts liabilities | |
| 101 | | |
| 136 | |
Total current liabilities | |
| 188 | | |
| 211 | |
| |
| | | |
| | |
Stockholder loans | |
| 303 | | |
| 297 | |
| |
| | | |
| | |
Total liabilities | |
| 491 | | |
| 508 | |
| |
| | | |
| | |
Stockholders’ Equity | |
| | | |
| | |
Common stock of US$ 0.0001 par value each (“Common Stock”): 100,000,000 shares authorized as of September 30, 2022 and December 31, 2021; issued and outstanding 54,218,813 and 54,018,813 shares as of September 30, 2022 and December 31, 2021, respectively. | |
| 5 | | |
| 5 | |
Additional paid-in capital | |
| 9,500 | | |
| 9,115 | |
Accumulated deficit | |
| (6,913 | ) | |
| (6,019 | ) |
Total stockholders’ equity | |
| 2,592 | | |
| 3,101 | |
Total liabilities and stockholders’
equity | |
| 3,083 | | |
| 3,609 | |
The accompanying notes are an integral part
of the condensed consolidated financial statements.
UAS DRONE CORP.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE
LOSS
(USD in thousands, except share and per share data)
| |
Nine months ended | | |
Three months ended | |
| |
September 30 | | |
September 30 | |
| |
2022 | | |
2021 | | |
2022 | | |
2021 | |
| |
(Unaudited) | | |
(Unaudited) | |
| |
| | |
| | |
| | |
| |
Revenues | |
| - | | |
| 500 | | |
| - | | |
| - | |
Cost of revenues | |
| - | | |
| - | | |
| - | | |
| - | |
Gross profit | |
| - | | |
| 500 | | |
| - | | |
| - | |
| |
| | | |
| | | |
| | | |
| | |
Research and development expenses | |
| (20 | ) | |
| - | | |
| (11 | ) | |
| - | |
General and administrative expenses | |
| (881 | ) | |
| (918 | ) | |
| (223 | ) | |
| (485 | ) |
Other income | |
| - | | |
| 83 | | |
| - | | |
| (49 | ) |
Operating loss | |
| (901 | ) | |
| (335 | ) | |
| (234 | ) | |
| (534 | ) |
Financing income (expense), net | |
| 7 | | |
| (619 | ) | |
| (4 | ) | |
| (253 | ) |
Comprehensive loss | |
| (894 | ) | |
| (954 | ) | |
| (238 | ) | |
| (787 | ) |
| |
| | | |
| | | |
| | | |
| | |
Loss per share (basic and diluted) | |
| (0.02 | ) | |
| (0.02 | ) | |
| (0.00 | ) | |
| (0.01 | ) |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average number of shares of common stock outstanding | |
| 54,119,912 | | |
| 47,592,159 | | |
| 54,118,813 | | |
| 54,018,813 | |
The accompanying notes are an integral part
of the condensed consolidated financial statements.
UAS DRONE CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN
SHAREHOLDERS’ EQUITY
(USD in thousands, except share and per share data)
| |
Number of
Shares | | |
| | |
Additional
paid-in
capital | | |
Accumulated
deficit | | |
Total
stockholders’
equity | |
BALANCE AT DECEMBER 31, 2021 | |
| 54,018,813 | | |
| 5 | | |
| 9,115 | | |
| (6,019 | ) | |
| 3,101 | |
Share based compensation for services | |
| 100,000 | | |
| * | | |
| 180 | | |
| - | | |
| 180 | |
Comprehensive loss for three month ended March 31, 2022 | |
| - | | |
| - | | |
| - | | |
| (369 | ) | |
| (369 | ) |
BALANCE AT MARCH 31, 2022 (Unaudited) | |
| 54,118,813 | | |
| 5 | | |
| 9,295 | | |
| (6,388 | ) | |
| 2,912 | |
Share based compensation for services | |
| - | | |
| - | | |
| 143 | | |
| - | | |
| 143 | |
Comprehensive loss for three months ended June 30, 2022 | |
| - | | |
| - | | |
| - | | |
| (287 | ) | |
| (287 | ) |
BALANCE AT JUNE 30, 2022 (Unaudited) | |
| 54,118,813 | | |
| 5 | | |
| 9,438 | | |
| (6,675 | ) | |
| 2,768 | |
Share based compensation for services | |
| 100,000 | | |
| * | | |
| 62 | | |
| - | | |
| 62 | |
Comprehensive loss for three months ended September 30, 2022 | |
| - | | |
| - | | |
| - | | |
| (238 | ) | |
| (238 | ) |
BALANCE AT SEPTEMBER 30, 2022 (Unaudited) | |
| 54,218,813 | | |
| 5 | | |
| 9,500 | | |
| (6,913 | ) | |
| 2,592 | |
| |
Number of
Shares | | |
| | |
Additional
paid-in
capital | | |
Accumulated
deficit | | |
Total
stockholders’
equity (deficit) | |
BALANCE AT DECEMBER 31, 2020 | |
| 40,075,151 | | |
| 4 | | |
| 3,278 | | |
| (5,131 | ) | |
| (1,849 | ) |
Issuance of shares in exchange for convertible loans | |
| 1,093,884 | | |
| * | | |
| 345 | | |
| - | | |
| 345 | |
Share based compensation for services | |
| - | | |
| - | | |
| 38 | | |
| - | | |
| 38 | |
Comprehensive profit for three month ended March 31, 2021 | |
| - | | |
| - | | |
| - | | |
| 251 | | |
| 251 | |
BALANCE AT MARCH 31, 2021 (Unaudited) | |
| 41,169,035 | | |
| 4 | | |
| 3,661 | | |
| (4,880 | ) | |
| (1,215 | ) |
Issuance of shares in exchange for convertible loans | |
| 349,778 | | |
| * | | |
| 361 | | |
| - | | |
| 361 | |
Issuance of shares for cash (net of issuance expenses) | |
| 12,500,000 | | |
| 1 | | |
| 4,604 | | |
| - | | |
| 4,605 | |
Share based compensation for services | |
| - | | |
| - | | |
| 103 | | |
| - | | |
| 103 | |
Comprehensive loss for three month ended June 30, 2021 | |
| - | | |
| - | | |
| - | | |
| (418 | ) | |
| (418 | ) |
BALANCE AT JUNE 30, 2021 (Unaudited) | |
| 54,018,813 | | |
| 5 | | |
| 8,729 | | |
| (5,298 | ) | |
| 3,436 | |
Share based compensation for services | |
| - | | |
| - | | |
| 325 | | |
| - | | |
| 325 | |
Comprehensive loss for three month ended September 30, 2021 | |
| - | | |
| - | | |
| - | | |
| (787 | ) | |
| (787 | ) |
BALANCE AT SEPTEMBER 30, 2021 (Unaudited) | |
| 54,018,813 | | |
| 5 | | |
| 9,054 | | |
| (6,085 | ) | |
| 2,974 | |
(*) | represents amount less than $1 thousand. |
UAS DRONE CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(USD in thousands)
| |
Nine months ended | |
| |
September 30, | |
| |
2022 | | |
2021 | |
| |
(Unaudited) | |
CASH FLOWS FROM OPERATING ACTIVITIES: | |
| | |
| |
Net loss for the period | |
$ | (894) | | |
$ | (954 | ) |
Adjustments required to reconcile net loss for the period to net cash used in operating activities: | |
| | | |
| | |
Depreciation and amortization | |
| 2 | | |
| 2 | |
Stock based compensation | |
| 385 | | |
| 466 | |
Interest on loans | |
| 6 | | |
| 6 | |
Expenses with respect to convertible loans and debentures | |
| - | | |
| 291 | |
Expenses with respect to changes in fair value of option granted in
equity financing | |
| - | | |
| 283 | |
Increase in other current assets | |
| 4 | | |
| (31 | ) |
Increase in accounts payable | |
| 12 | | |
| (10 | ) |
Decrease in other accounts payable | |
| (35 | ) | |
| (117 | ) |
Net cash used in operating activities | |
| (520 | ) | |
| (64 | ) |
| |
| | | |
| | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
| | | |
| | |
Lease deposit | |
| (15 | ) | |
| - | |
Purchase of property and equipment | |
| (15 | ) | |
| - | |
Net cash used in investing activities | |
| (30 | ) | |
| - | |
| |
| | | |
| | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
| | | |
| | |
Proceeds from issuance of shares | |
| - | | |
| 4,649 | |
Repayments of convertible loans | |
| - | | |
| (954 | ) |
Repayments of long term banking institute | |
| - | | |
| (6 | ) |
Net cash provided by financing activities | |
| - | | |
| 3,689 | |
| |
| | | |
| | |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | |
| (550 | ) | |
| 3,625 | |
| |
| | | |
| | |
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | |
| 3,560 | | |
| 105 | |
| |
| | | |
| | |
CASH AND CASH EQUIVALENTS AT END OF PERIOD | |
| 3,010 | | |
| 3,730 | |
Supplemental disclosure of cash flow information: | |
| | |
| |
Cash paid during the year for: | |
| | |
| |
Interest | |
| - | | |
| 59 | |
Non-cash transactions: | |
| | | |
| | |
Issuance of shares in exchange for convertible loans | |
| - | | |
| 706 | |
Value of option recorded as issuance expenses | |
| - | | |
| 44 | |
The accompanying notes are an integral part
of the condensed consolidated financial statement
UAS DRONE CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(USD in thousands, except share and per share data)
NOTE 1 -
GENERAL
UAS Drone Corp. (“the Company”
or “USDR”) was incorporated under the laws of the State of Nevada on February 4, 2015. Prior to the Company’s formation,
the operations were functioning under Unlimited Aerial Systems, LLP (“UAS LLP”). UAS LLP was formed under the laws of the
State of Louisiana on August 22, 2014. Effective March 31, 2015, the Company completed a reverse merger with UAS LLP. The reverse merger
was accounted for as a reverse capitalization.
On March 9, 2020, the Company closed
on the Share Exchange Agreement (as defined hereunder), pursuant to which, Duke Robotics, Inc. (“Duke Inc.”) a corporation
incorporated under the laws of the state of Delaware, became a majority-owned subsidiary of the Company. Duke Inc. has a wholly-owned
subsidiary, Duke Airborne Systems Ltd. (“Duke Israel,” and collectively with Duke Inc., “Duke”), which was formed
under the laws of the State of Israel in March 2014 and became the sole subsidiary of Duke after its incorporation.
On April 29, 2020, the Company, Duke
Inc., and UAS Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of the Company (“UAS Sub”), executed
an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which UAS Sub merged with and into Duke Inc., with Duke
Inc. surviving as our wholly-owned subsidiary (the “Short-Form Merger”). Upon closing of the Short-Form Merger, each outstanding
share of UAS Sub’s common stock, par value $0.0001 per share, was converted into and became one share of common stock of Duke Inc.,
with Duke Inc. surviving as a wholly-owned subsidiary of the Company.
The Company (collectively with Duke,
the “Group”) is a robotics company dedicated to the development of an advanced robotics stabilization system that enables
remote, real-time, pinpoint accurate firing of small arms and light weapons. The Company’s advanced robotics system is able to achieve
pinpoint accuracy regardless of the movement of the weapons platform or the target.
Effective October 22, 2020, Company’s
common stock in quoted on the OTC Markets Group, Inc.’s OTCQB® tier Venture Market, under the symbol “USDR”.
The COVID-19 pandemic has caused states
of emergency to be declared in various countries, travel restrictions imposed globally, quarantines established in certain jurisdictions
and various institutions and companies being closed. COVID-19 has also adversely impacted the Group’s ability to conduct its business
effectively due to disruptions to its capabilities, availability and productivity of personnel, while the Group simultaneously attempts
to comply with rapidly changing restrictions, such as travel restrictions, curfews and others. Although to date these restrictions have
not impacted the Group’s operations, the effect on its business, from the spread of COVID-19 and the actions implemented by the
governments of the State of Israel, the United States and elsewhere across the globe, may worsen over time.
UAS DRONE CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(USD in thousands, except share and per share data)
NOTE 1
- GENERAL (cont.)
The spread of COVID-19 may also result
in the inability of the Group’s manufacturers to deliver components or finished products on a timely basis and may also result in
the inability of the Group’s suppliers to deliver the parts required by its manufacturers to complete manufacturing of components
or finished products. In addition, governments may divert spending from other budgeted resources as they seek to reduce and/or stop the
spread of COVID-19. Such events may result in a period of business and manufacturing disruption, and in reduced operations, any of which
could materially affect the Group’s business, financial condition and results of operations. The extent to which COVID-19 impacts
the Group’s business will depend on future developments, which are highly uncertain and cannot be predicted, including new information
which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among others. The Group
is actively monitoring the pandemic and it is taking any necessary measures to respond to the situation in cooperation with the various
stakeholders.
Unaudited Interim Financial Statements
The accompanying unaudited condensed
consolidated financial statements include the accounts of the Company and its subsidiary, prepared in accordance with accounting principles
generally accepted in the United States of America (“GAAP”) and with the instructions to Form 10-Q. In the opinion of management,
the financial statements presented herein have not been audited by an independent registered public accounting firm but include all material
adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the
financial condition, results of operations and cash flows for the nine-months ended September 30, 2022. However, these results are not
necessarily indicative of results for any other interim period or for the year ended December 31, 2021. The preparation of financial statements
in conformity with GAAP requires the Company to make certain estimates and assumptions for the reporting periods covered by the financial
statements. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts
could differ from these estimates.
Certain information and footnote disclosures
normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant to the
rules of the U.S. Securities and Exchange Commission (“SEC”). These financial statements should be read in conjunction with
the financial statements and notes thereto contained in the Company’s Annual Report published with the SEC, for the year ended December
31, 2021.
UAS DRONE CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (unaudited)
(USD in thousands, except share and per share data)
NOTE 2 -
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION
Principles of Consolidation
The consolidated financial statements
are prepared in accordance with GAAP. The consolidated financial statements of the Company include the Company and its wholly-owned and
majority-owned subsidiaries. All inter-company balances and transactions have been eliminated.
Use of Estimates
The preparation of unaudited condensed
consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure
of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. As
applicable to these financial statements, the most significant estimates and assumptions relate to share based compensation.
Derivative Liabilities and Fair
Value of Financial Instruments
Fair value accounting requires bifurcation
of embedded derivative instruments such as conversion features in convertible debt or equity instruments and measurement of their fair
value for accounting purposes. In assessing the convertible debt instruments, management determines if the convertible debt host instrument
is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not
considered conventional convertible debt under Accounting Standards Codification (“ASC”) 470, the Company will continue its
evaluation process of these instruments as derivative financial instruments under ASC 815.
Once determined, derivative liabilities
are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results
of operations as an adjustment to fair value of derivatives.
Fair value of certain of the Company’s
financial instruments including cash, accounts receivable, account payable, accrued expenses, notes payables, and other accrued liabilities
approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair
Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally
accepted accounting principles and expands disclosures about fair value investments.
Fair value, as defined in ASC 820,
is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most
advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of non-performance,
which includes, among other things, the Company’s credit risk.
Valuation techniques are generally
classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one
or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability,
and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable
inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as
follows:
Level 1: Quoted prices (unadjusted)
in active markets that are accessible at the measurement date for identical assets or liabilities.
UAS DRONE CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (unaudited)
(USD in thousands, except share and per share data)
NOTE 2 -
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (cont.)
Level 2: Quoted prices for similar
assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active;
inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated
by observable market data for substantially the full term of the assets or liabilities; and
Level 3: Unobservable inputs for the
asset or liability that are supported by little or no market activity, and that are significant to the fair values.
Fair value measurements are required
to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements
using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation
of the beginning and ending balances, separately presenting changes during the period attributable to the following: total gains or losses
for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains
or losses included in earning are reported in the statement of income.
Recent Accounting Pronouncements
On October 1, 2021, the Company early adopted Accounting Standards
Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts
in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU
2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible
debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments
and requires the use of the if-converted method. The new standard was effective for us beginning January 1, 2022, with early adoption
permitted. The adoption of this new standard did not have a material impact on our consolidated financial statements.
In June 2022, the Financial Accounting
Standards Board issued ASU 2022-03, “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to
Contractual Sale Restrictions”, which clarifies that a contractual restriction on the sale of an equity security is not considered
part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also clarify
that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. This guidance also requires
certain disclosures for equity securities subject to contractual sale restrictions. The new guidance is required to be applied prospectively
with any adjustments from the adoption of the amendments recognized in earnings and disclosed on the date of adoption. This guidance is
effective for the Company for the year ending March 31, 2025 and interim reporting periods during the year ending March 31, 2025. Early
adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on the financial position,
results of operations and cash flows.
Other new pronouncements issued but
not effective as of September 30, 2022 are not expected to have a material impact on the Company’s consolidated financial statements.
UAS DRONE CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(USD in thousands, except share and per share data)
NOTE 3 -
SHAREHOLDERS’ EQUITY
On March 1, 2022, the Company signed an investor relations service
agreement with a consultant pursuant to which the Company agreed to pay the consultant a monthly retainer and in addition, to issue the
consultant 300,000 restricted shares of common stock, to be issued in three tranches. In the event that the agreement is terminated prior
to the issuance date, the remaining share obligation shall be void. On March 17, 2022, the Company issued 100,000 restricted shares of
Common Stock pursuant to the agreement. On July 13, 2022 the Company issued 100,000 restricted shares of Common Stock pursuant to the
agreement. On September 22, 2022, the Company decided to terminate the service agreement. The Company determined the value of the shares
issued based on the agreement date at $30 of which were recorded as share based compensation expenses in the nine months ended September
30, 2022.
As detailed in Note 8 to the financial statement as of December 31,
2021, on May 11, 2021, the Company issued certain warrants (the “Warrants”) to purchase up to 12,500,000 shares of the Company’s
Common Stock to eight (8) non-U.S. investors (the “Investors”). The Warrants were exercisable immediately, had a term of 18
months and have an exercise price of $0.40 per share. On April 5, 2022, the Company and the Investors executed an extension agreement
(the “Extension”), such that the term of the Warrants was extended so that they now expire on November 11, 2023. The fair
value of the expected additional cash payments as of September 30, 2022 was estimated at $29.
NOTE 4 -
STOCK OPTIONS
The following table presents the Company’s
stock option activity the nine months ended September 30, 2022:
| |
Number of
Options | | |
Weighted
Average
Exercise Price | |
Outstanding at December 31,2021 | |
| 2,426,812 | | |
| 0.81 | |
Granted | |
| - | | |
| - | |
Exercised | |
| - | | |
| - | |
Forfeited or expired | |
| - | | |
| - | |
Outstanding on September 30, 2022 | |
| 2,426,812 | | |
| 0.81 | |
Number of options exercisable on September 30, 2022 | |
| 1,387,092 | | |
| 0.95 | |
The aggregate intrinsic value of the
awards outstanding as of September 30, 2022 is $92. These amounts represent the total intrinsic value, based on the Company’s stock
price of $0.21 as of September 30, 2022, less the weighted exercise price. This represents the potential amount received by the option
holders had all option holders exercised their options as of that date.
UAS DRONE CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(USD in thousands, except share and per share data)
NOTE 4 -
STOCK OPTIONS (cont.)
The stock options outstanding as of
September 30, 2022, have been separated into exercise prices, as follows:
Exercise price | | |
Stock options outstanding | | |
Weighted average remaining contractual life – years | | |
Stock options vested | |
| | |
As of September, 30, 2022 | |
| 0.0001 | | |
| 450,000 | | |
| 3.48 | | |
| 225,000 | |
| 0.38 | | |
| 1,256,822 | | |
| 4.78 | | |
| 628,412 | |
| 1.00 | | |
| 99,369 | | |
| 4.75 | | |
| 99,369 | |
| 2.25 | | |
| 620,621 | | |
| 4.75 | | |
| 434,311 | |
| | | |
| 2,426,812 | | |
| 4.53 | | |
| 1,387,092 | |
The stock options outstanding as of
December 31, 2021, have been separated into exercise prices, as follows:
Exercise price | | |
Stock options outstanding | | |
Weighted average remaining contractual life – years | | |
Stock options vested | |
| | |
As of December 31, 2021 | |
| 0.0001 | | |
| 450,000 | | |
| 4.23 | | |
| - | |
| 0.38 | | |
| 1,256,822 | | |
| 5.53 | | |
| - | |
| 1.00 | | |
| 99,369 | | |
| 5.5 | | |
| - | |
| 2.25 | | |
| 620,621 | | |
| 5.5 | | |
| - | |
| | | |
| 2,426,812 | | |
| 4.78 | | |
| - | |
Compensation expense recorded by the
Company in respect of its stock-based compensation awards for the period ended September 30, 2022 was $355 and are included in General
and Administrative expenses in the Statements of Operations.
NOTE 5 - AGREEMENTS
| 1. | On April 4, 2022, the Company signed a lease agreement for an office space
in Mevo Carmel Science and Industry Park, Israel for a term of 3 years, with an option to extend the term of the lease agreement for an
additional 2 years. The monthly lease payments under the lease agreement, for the first two years are approximately $5,200 and for the
third year approximately $5,400. The monthly lease payments for the option period will be agreed between the parties, with a minimum increase
of 5% above the third years monthly payments. Per the lease agreement, the Company expects that the property will be available for Company’s
use 5 months following the execution date, therefore commencement date of the lease agreement as not yet been met. Based on the lease
agreement terms, the Company made a deposit of $15 as a guarantee for its lease commitments. |
| 2. | On August 15, 2022 Duke Israel, signed a Collaboration
and Development Agreement with the Israel Electric Corporation Ltd. (IEC), to implement and test during a pilot with IEC a robotic drone-enabled
system for cleaning electric utility insulators (“IC Drone”), that is in development by Duke Israel. ICE is a public
and 99% government-owned company that generates, transmits, and supplies electricity to all sectors of the State of Israel. |
UAS DRONE CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(USD in thousands, except share and per share data)
NOTE 6 -
RELATED PARTIES
| A. | Transactions and balances with related parties |
| |
Nine months ended
September
30, | | |
Three months ended
September 30, | |
| |
2022 | | |
2021 | | |
2022 | | |
2021 | |
| |
| | |
| | |
| | |
| |
General and administrative expenses: | |
| | |
| | |
| | |
| |
Directors and Officers compensation (*) | |
| 390 | | |
| 420 | | |
| 108 | | |
| 198 | |
| |
| | | |
| | | |
| | | |
| | |
(*)Share base compensation | |
| 126 | | |
| 186 | | |
| 22 | | |
| 102 | |
| |
| | | |
| | | |
| | | |
| | |
Financing: | |
| | | |
| | | |
| | | |
| | |
Financing expense | |
| 6 | | |
| 6 | | |
| 2 | | |
| 2 | |
| |
| | | |
| | | |
| | | |
| | |
| B. | Balances with related parties: |
| |
| | |
As of
December 31, | |
| |
2022 | | |
2021 | |
| |
| | |
| |
Other accounts liabilities | |
| 32 | | |
| 30 | |
Stockholders loans | |
| 281 | | |
| 276 | |
| C. | On March 25, 2021, the Board of Directors appointed Yossi Balucka to serve as its Chief Executive Officer. Mr. Balucka is entitled to a monthly fee of NIS30,000 (approximately $9,650), reimbursement of expenses and discretionary performance bonus. In conjunction with the appointment of Mr. Balucka, the Company issued to Mr. Balucka options to purchase 450,000 shares of the Company’s commons stock at an exercise price of $0.0001 per share, subject to and in accordance with the terms and conditions of an Option Plan. The options shall vest over a three year period, with 50% of the options to vest on the first anniversary of the grant date, and the balance of 50% of the options to vest in equal parts on the second and third anniversary of the grant date, respectively, subject to the Mr. Balucka providing continued services to the Company. The fair value of the options was determined using the Black-Scholes pricing model, assuming a risk free rate of 0.07%, a volatility factor of 156.12%, dividend yields of 0% and an expected life of 5 years. The total value of share-based compensation was estimated to an amount of $189. The total share-based compensation expenses during the nine month ended September 30, 2022 amounted to $52. |
UAS DRONE CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(USD in thousands, except share and per share data)
NOTE 6 -
RELATED PARTIES (cont.)
In addition, in July 2021, the Board
of Directors of the Company approved the issuance options to purchase an aggregate of 490,000 shares of the Company’s Common Stock
to its Vice Chairman, directors and Chief Financial Officer. The options shall vest over a three-year period, with 50% of the options
to vest on the first anniversary of the grant date, and the balance of 50% of the options to vest in equal parts on the second and third
anniversary of the grant date.
The fair value of the options was determined
using the Black-Scholes pricing model, assuming a risk free rate of 0.07%, a volatility factor of 156.12%, dividend yields of 0% and an
expected life of 6 years. Total value of share-based compensation was estimated to an amounted of $176. Total share-based compensation
expenses during the nine month ended September 30, 2022 amounted to $74.
Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations
Readers are advised to
review the following discussion and analysis of our financial condition and results of operations together with our consolidated financial
statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and the consolidated financial statements
and related notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2021. Some of the information contained in
this discussion and analysis or set forth elsewhere in this Quarterly Report, including information with respect to our plans and strategy
for our business, includes forward-looking statements that involve risks and uncertainties. See “Cautionary Note Regarding Forward-Looking
Statements”. You should review the “Risk Factors” section of our Annual Report for the fiscal year ended December 31,
2021 for a discussion of important factors that could cause actual results to differ materially from the results described in or implied
by the forward-looking statements contained in the following discussion and analysis.
We are a robotics company
dedicated to the development of an advanced robotics system that enables remote, real-time, pinpoint accurate firing of small arms and
light weapons. Our advanced robotics system is able to achieve pinpoint accuracy regardless of the movement of the weapons platform or
the target.
We were founded in 2014 as
Unlimited Aerial Systems, LLP (“UAS LLP”), and until the consummation of the Share Exchange Agreement (as hereinafter defined),
we were a developer and manufacturer of commercial unmanned aerial systems, or drones, with the goal of providing a superior Quadrotor
aerial platform at an affordable price point in the law enforcement and first responder markets.
On March 9, 2020, we closed
on the Share Exchange Agreement (the “Share Exchange Agreement”), pursuant to which Duke Robotics, Inc., a Delaware corporation
(“Duke”) became our majority-owned subsidiary (the “Share Exchange”). Such closing date is referred to as the
“Effective Time.” As a result of the Share Exchange, the Company adopted the business plan of Duke.
On April 29, 2020, we, Duke,
and UAS Acquisition Corp., a Delaware corporation and our wholly-owned subsidiary (“UAS Sub”), executed an Agreement and
Plan of Merger (the “Merger Agreement”), pursuant to which UAS Sub was to merge, upon the satisfaction of customary closing
conditions, with and into Duke, with Duke surviving as our wholly-owned subsidiary (the “Short-Form Merger”). Pursuant to
the Merger Agreement, we intended to acquire the remaining outstanding shares of Duke held by those certain Duke shareholders that did
not participate in the Share Exchange. On June 25, 2020, Duke filed a Certificate of Merger with the State of Delaware, and consequently,
Duke became our wholly-owned subsidiary and the Short-Form Merger was consummated.
Duke has a wholly-owned subsidiary,
Duke Airborne Systems Ltd. (“Duke Israel”), which was formed under the laws of the State of Israel in March 2014 and became
the sole subsidiary of Duke after its incorporation. Our mailing address is 10 HaRimon Street, Mevo Science and Industrial Park, Israel,
2069203, and our telephone number is 011-972-4-8124101.
Readers are cautioned that
to date, we have generated limited revenues and have not yet begun meaningful commercialization efforts with respect to our products.
We intend in the long-term to derive substantial revenues from the sales of our products as well as future models of other robots and
our unmanned aerial system (“UAS”) platforms for both military and civilian use, but there can be no assurance that we will
be able to do so.
On January 29, 2021, we,
through Duke Israel, and Elbit Systems Land Ltd., an Israeli corporation (“Elbit”), entered into a collaboration agreement
(the “Collaboration Agreement”) for the global marketing and sales, and the production and further development of our developed
advanced robotic system mounted on an UAS, armed with lightweight firearms, which we market under the commercial name “TIKAD.”
On
August 15, 2022, Duke Israel introduced the IC Drone, a drone technology for conducting routine maintenance of critical infrastructure,
and has signed an agreement with Israel Electric Corporation (IEC) to provide drone-enabled systems for cleaning electric utility cable
insulators.
As of the date of this quarterly
report, to date, we have not experienced any material impact on our financial condition and results of operations due to COVID-19, and
we do not expect to experience any material impact on our overall liquidity positions and outlook as a result of the outbreak. Nevertheless,
given that COVID-19 is still an ongoing event in different parts of the world, it is still not possible at this time to estimate the
full impact that the COVID-19 pandemic, the continued spread of COVID-19, and any additional measures taken by governments, health officials
or by us in response to such spread, could have on our business results of operations and financial condition.
Critical Accounting Policies
Please see Note 2 of Part
I, Item 1 of this Quarterly Report on Form 10-Q for the summary of significant accounting policies. In addition, reference is made to
Part I, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation of our Annual Report on Form
10-K for the year ended December 31, 2021 (filed on March 7, 2022) with respect to our Critical Accounting Policies and Estimates. The
main changes to our critical accounting policies and estimates since our Annual Report on Form 10-K for the year ended December 31, 2021,
relates to convertible loans Derivative Liabilities and Fair Value of Financial Instruments.
Results of Operations
Comparison of the three months ended September 30, 2022 and
2021
Revenues. We did not
generate any revenues during the three months ended September 30, 2022 and September 30, 2021.
Research and Development.
Our research and development expenses for the three months ended September 30, 2022, amounted to $11,000, compared to $0 for the three
months ended September 30, 2021. Our research and development expenses, for the three months ended September 30, 2022, consisted primarily
of professional services.
General and Administrative.
Our general and administrative expenses for the three months ended September 30, 2022, which consisted primarily of professional services,
stock-based compensation expenses and legal expenses, amounted to $223,000, compared to $485,000 for the three months ended September
30, 2021. The decrease in general and administrative expenses for the three months ended September 30, 2022 was mainly due to a decrease
in share based compensation expenses of $264,000.
Financial Income (expense).
For the three months ended September 30, 2022, we had financial expense of $4,000 compared to financial expense of $253,000 for the three
months ended September 30, 2021. The reason for the decrease in financial expense for the three months ended September 30, 2022, was
mainly due to the decrease in interest expense related to our previously outstanding convertible loans which have been repaid or converted
in full.
Net Loss. We incurred
a net loss of $238,000 for the three months ended September 30, 2022 as compared to $787,000 for the three months ended September 30,
2021, for the reasons set forth above.
Comparison of the nine months ended September 30, 2022 and 2021
Revenues. We did not
generate any revenues during the nine months ended September 30, 2022. We had revenues of $500,000 for the nine months ended September
30, 2021, which were derived from the Collaboration Agreement.
Research and Development.
Our research and development expenses for the nine months ended September 30, 2022, amounted to $20,000, compare to none for the
nine months ended September 30, 2021. Our research and development expenses, for the nine months ended September 30, 2022, consisted
primarily of professional services.
General and Administrative.
Our general and administrative expenses for the nine months ended September
30, 2022, which consisted primarily of professional services, stock-based compensation expenses and legal expenses, amounted to $881,000,
compared to $918,000 for the nine months ended September 30, 2021. The decrease in general and administrative expenses for the nine months
ended September 30, 2022 was mainly due to a decrease in share based compensation of $82,000 expenses, partially offset by increase in
professional services.
Other Income. For
the nine months ended September 30, 2021 we had other income of $83 mainly resulting from waiver of consulting fees accrued by March
31, 2021.
Financial Income (expense).
For the nine months ended September 30, 2022, we had financial income of $7,000 compared to financial expense of $619,000 for the
nine months ended September 30, 2021. The reason for the decrease in financial expense for the nine months ended September 30, 2022,
was mainly due to the decrease in interest expense related to our previously outstanding convertible loans which have been repaid or
converted in full.
Net Loss. We incurred
a net loss of $894,000 for the nine months ended September 30, 2022 as compared to a net loss of $954,000 for the nine months ended September
30, 2021, for the reasons set forth above.
Liquidity and Capital Resources
We had $3,010,000 in cash on September 30, 2022 versus $3,730,000 in
cash on September 30, 2021. The reason for the decrease in our cash balance was due to the operating expenses describe above. Cash used
in operations for the nine months ended September 30, 2022 was $520,000 as compared to cash provided by operations of $64,000 for the
nine months ended September 30, 2021. The reason for the increase in cash used in operations is mainly related to our net loss and the
decrease in expenses with respect to convertible loans and debentures, expenses with respect to changes in fair value of option granted
in an equity financing and in stock-based compensation.
Net
cash used in investing activities was $30,000 for the nine months ended September 30, 2022, as compared to net cash used in financing
activities of $0 for the nine months ended September 30, 2021. The increase is related to investments in office improvements and lease
deposit.
Net cash provided by in financing
activities was $0 for the nine months ended September 30, 2022, as compared to net cash used in financing activities of $3,689,000 for
the nine months ended September 30, 2021. The decrease is a result of proceeds from a private placement transaction we completed in May
2021 and the full repayment of a convertible loans in 2021.
On September 2, 2019, we executed a promissory note having a total
principal amount of $35,000 bearing interest at a 6% per annum and maturing on September 2, 2021 (the “Promissory Note”).
The Promissory Note was a non-recourse and carried no personal guarantees. In conjunction with the consummation of the Share Exchange,
and as a condition thereof, on March 6, 2020, we entered into several Securities Exchange Agreements, on the same terms, to exchange the
Promissory Note for 9,623,621 shares of our common stock, par value $0.0001 per share (the “Common Stock”). On May 18, 2021,
we issued 54,019 shares of Common Stock of the Company, to several holders pursuant to the terms of the Security Exchange Agreements pursuant
to which, such holders were entitled to an anti-dilution clause in the event that the Convertible Debentures were converted into shares
of our Common Stock.
In connection with the Share Exchange, immediately prior to the Effective
Time, we entered into several convertible loan agreements, on the same terms, in the aggregate amount of $965,000 (each, a “Convertible
Loan Agreement”). The terms of the Convertible Loan Agreements required repayment of the borrowed amount by the one-year anniversary
of the Effective Time, unless, at our discretion, and subject to its compliance with any and all terms of the material terms of the Convertible
Loan Agreements, the term of such loans is extended for an additional twelve (12) month period. The terms of the Convertible Loan Agreements
also provide that we may repay any portion of the remaining outstanding loan amount, without penalty, provided, however, that the Company
provides the specific lender with three business days’ written notice prior to such repayment, during which time the lender may
elect to convert any or all of the outstanding loan amount into shares of Common Stock of the Company. The Convertible Loan Agreements
bore simple interest at a rate equal to 15% per annum, payable on the 15th day of each calendar month. On December 9, 2020, we utilized
our rights under the Convertible Loan Agreements and extended the terms of the loans for an additional twelve months. During May 2021,
we repaid the full balance of the principal of the Convertible Loans in the amount of $835,000.
Also, in connection with
the Share Exchange, we entered into securities exchange agreements (each, an “Exchange Agreement”) with our outstanding debt
holders, Alpha Capital Anstalt (“Alpha”) and GreenBlock Capital LLC (“GBC”) to respectively cancel existing debentures
or debt in the total amount of $658,323 and in exchange issue new debentures in the aggregate amount of $400,000 and issue 698,755 and
65,198 shares of Common Stock to each of Alpha and GBC, respectively. The New Debentures matured three years from the Effective Date,
bore interest at a rate of 8% per year and were only convertible into shares of the Company’s Common Stock, at an original conversion
price of $0.3740 (the “Original Conversion Price”); provided, however, that such Original Conversion Price shall be adjusted
downward in the event that the Company, as applicable, sells or grants any options to purchase or sells or grants any right to reprice,
or otherwise dispose or issues any Common Stock or common stock equivalents entitling any purchaser to acquire shares of the Company’s
Common Stock at an effective price per share that is lower than the Original Conversion Price (such issuance, a “Dilutive Event”).
In the event of a Dilutive Event at any time from the Effective Time through the six (6) month anniversary of the Effective Time, any
such adjustment shall occur immediately after the completion of such period. Subsequent to March 31, 2021, a portion of the Convertible
Debentures, representing an aggregate amount of $110,614 (including interest) was converted into 295,759 shares of Common Stock. During
May 2021, we prepaid the full balance of the principal and interest amount of the Convertible Debentures in the amount of $108,541.
On May 11, 2021, we entered
into Securities Purchase Agreements with eight (8) non-U.S. investors (the “Investors”), pursuant to which we, in a private
placement offering (the “Offering”), agreed to issue and sell to the Investors an aggregate of: (i) 12,500,000 shares of
our Common Stock at a price of $0.40 per share; and (ii) warrants (the “Warrants”) to purchase 12,500,000 of our Common Stock.
The Warrants are exercisable immediately and for a term of 18 months and have an exercise price of $0.40 per share. The aggregate gross
proceeds from the Offering were approximately $5,000,000 and the Offering closed on May 11, 2021. On April 5, 2022, we entered into an
agreement with the Investors pursuant to which we extended the term of the Warrants, which now expire on November 11, 2023. The fair
value of the expected additional cash payments as of September 30, 2022 was estimated at $29.
In view of our cash balance
following the above transactions, we anticipate that our cash balances will be sufficient to permit us to conduct our operations up to
the end of 2023. We may also satisfy its liquidity through the sale of its securities, either in public or private transactions.
If we are unable to obtain sufficient amounts of additional capital,
we may be required to reduce the scope of our planned development, which could harm our business, financial condition and operating results.
If we obtain additional funds by selling any of our equity securities or by issuing Common Stock to pay current or future obligations,
the percentage ownership of our stockholders will be reduced, stockholders may experience additional dilution, or the equity securities
may have rights preferences or privileges senior to the Common Stock. If adequate funds are not available to us when needed on satisfactory
terms, we may be required to cease operating or otherwise modify our business strategy.